Novartis Pharmaceutical Administration System, EPO Patent

The European Patent Office published patent application EP3596635A1, filed by Novartis AG, titled 'System for Administering a Pharmaceutical Product.' The patent covers pharmaceutical administration technology including drug delivery devices and related systems, classified under multiple IPC codes spanning G16H (health informatics), A61M (medical devices), and related categories. The patent is granted with designation across 34 European Patent Convention contracting states.

Roche Patents Blood Glucose Prediction System for Adverse Range Determination

The European Patent Office published patent application EP3651164A1, filed by Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG, and mySugr GmbH. The patent covers methods and systems for determining the probability of a patient's blood glucose value falling within an adverse range at a specified prediction time. The patent is classified under G16H 50/20, 50/30, and 50/70 for health informatics diagnostics.

EP3797421A1, ZOE Limited, Nutritional Response Accuracy

The European Patent Office published patent EP3797421A1 for ZOE Limited, covering methods and systems for improving the accuracy of measuring nutritional responses in non-clinical settings. The patent names George Hadjigeorgiou, Jonathan Thomas Wolf, and Richard James Davies as inventors, with IPC classifications in health informatics (G16H). The patent is effective as of the publication date.

Self Learning Hydration Method by Riprup

EPO granted patent EP3745410A1 to Riprup Company S.A. for a self-learning method of hydrating a human. The invention, classified under G16H 20/60 (drugs) and G16H 50/20 (diagnosis/Wellbeing), covers a hydration optimization method using personalized data. The patent is validated in 39 designated contracting states including all EU member states and the UK.

Samsung Activity Pattern System Patent, EP3545522A1, Published Apr 2026

The European Patent Office published patent application EP3545522A1, filed by Samsung Electronics Co., Ltd., titled 'Method for Providing Activity Information Related to Activity Pattern of User and Electronic Device.' The application covers systems and methods for tracking and providing user activity pattern information via an electronic device, classified under IPC G16H (Health Informatics). The patent designates all major European Contracting States including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Microsoft Automated Chatting Psychological Cure Patent

The European Patent Office published Microsoft Technology Licensing's patent application for an automated system to assist psychological treatment through chatbot interactions. The publication covers designated EU member states and marks the commencement of the formal examination process.

EP3448870A1: Tubulin Tyrosine Ligase Enzyme Substrates

The European Patent Office published patent application EP3448870A1 on April 15, 2026, titled 'Unusual Substrates of Tubulin Tyrosine Ligase.' The patent names Forschungsverbund Berlin E.V. and Ludwig-Maximilians-Universität München as applicants, with six named inventors including Hackenberger, Schumacher, Helma, and Leonhardt. The application covers biotechnological enzyme substrates classified under C07K 1/107 and C12N 9/00, with designation extending across 32 European states.

Faecalibacterium Longum Patent EP3511406A1, BGI Shenzhen, Apr 15, 2026

The European Patent Office published patent application EP3511406A1 for Faecalibacterium Longum, a bacterial strain with applications in food supplements and pharmaceutical compositions. Applicant BGI Shenzhen seeks protection across 32 designated EU and EEA contracting states including Germany, France, the United Kingdom, Italy, and Spain. The patent covers compositions for metabolic applications including anti-obesity treatments.

DSG2 Monoclonal Antibody - EP3464355A1 - Asclepiumm Taiwan

The European Patent Office published patent application EP3464355A1 for a DSG2 monoclonal antibody and use thereof, filed by Asclepiumm Taiwan Co., Ltd. The application names CHEN Min-Che, CHANG Po-Hao, and LIU Ya-Chuan as inventors. The patent covers immunological compositions classified under IPC C07K 16/28, C12N 15/13, A61K 39/395, and A61P 35/00, with designated states spanning all current EPO member states and extension states.

EPO Publishes Protein Article Patent EP3632988A1

The European Patent Office published patent application EP3632988A1 titled 'Protein Molded Article And Method For Producing Same, Protein Solution, And Protein Molded Article Plasticizer.' The application designates 33 European states and lists Institute of National Colleges of Technology, Japan and Spiber Inc. as applicants. The invention covers protein-based molded articles, production methods, protein solutions, and plasticizers for such articles.

Separating Agent for Human Serum IgG Antibodies

The European Patent Office published application EP3375875A1, a patent for a separating agent for human serum-derived IgG polyclonal antibodies and the method of separation. The applicants are National University Corporation, Kyoto Institute of Technology, and Daicel Corporation. The invention covers IPC classifications C07K, C12N, and C12Q related to immunoglobulin separation.

EP3380614A1 Cancer Treatment Agents, Vall Hebron Research Institute, Published

The European Patent Office published patent application EP3380614A1 titled 'Agents for the Treatment of Diseases Associated with Undesired Cell Proliferation,' filed by Fundació Privada Institut d'Investigació Oncològica de Vall Hebron and Institució Catalana de Recerca I Estudis Avançats. The application covers therapeutic agents targeting cell proliferation diseases, with classification under C12N 15/113, C07K 16/22, and A61P 35/00 (oncology). The patent is designated across 30 European member and extension states.

Promoters for Heterologous Gene Expression EP3294890A1

The European Patent Office granted publication EP3294890A1 for a patent application titled 'Promoters for Expression of Heterologous Genes', filed by Children's Medical Research Institute and The Sydney Children's Hospitals Network (Randwick and Westmead). The application covers C12N-classified biotechnological inventions directed to gene expression promoters, with international patent protection sought across 30 EU/EEA and附属 designated states including DE, FR, GB, NL, and SE.

Faecalibacterium Butyricigenerans Patent EP3498819A1, BGI Shenzhen

The European Patent Office published patent application EP3498819A1, filed by BGI Shenzhen, covering Faecalibacterium Butyricigenerans and its method of cultivation. The application, filed by six named inventors, covers the bacterial strain and its therapeutic and pharmaceutical applications as classified under IPC C12N, A61K, and A61P. The patent designates all EU member states along with Switzerland, the UK, Norway, Turkey, and other European countries.

Magnetically Immobilized Microbiocidal Enzymes, ZYMtronix, 15th Apr

The European Patent Office published patent application EP3297442A1 titled 'Magnetically Immobilized Microbiocidal Enzymes' filed by ZYMtronix, Inc. The invention relates to the use of magnetically immobilized microbiocidal enzymes for antimicrobial applications. The patent application was published on 15 April 2026 under EPC procedure, with designated states covering all EU member states plus associated countries.

EP3630984A1 Coffee Bean Extractability Method, Tropic Biosciences

The European Patent Office published patent application EP3630984A1 for Tropic Biosciences UK Limited on 15 April 2026. The patent covers compositions and methods for increasing extractability of solids from coffee beans. The application designates 37 states including EU member states, the UK, Switzerland, Norway, and Turkey.

Caltech X Chromosome Gene Reactivation Patent EP3286310A1

The European Patent Office granted Patent EP3286310A1 to the California Institute of Technology covering methods for reactivating X chromosome genes. The invention relates to therapeutic and diagnostic applications in genetic medicine, classified under multiple IPC codes including C12N, C12Q, and A61K.

DNA Damage Response Therapy, Italian Applicants, Apr 15 2026

The European Patent Office published patent application EP3642337A1 titled 'Therapy and Diagnosis of Disease Characterised by Alterations in the DNA Damage Response'. The applicants are IFOM – Fondazione Istituto FIRC di Oncologia Molecolare and Istituto Europeo di Oncologia S.r.l., both Italian cancer research institutions. The application is classified under C12N 9/16, A61K 31/155, and A61K 8/68, with designated states covering all European Patent Convention member states and extension states.

Memphis Athletics and Nobody Trashes Tennessee Team Up for Blue & Gray Cleanup Day on April 22

The Tennessee Department of Transportation (TDOT) and Memphis Athletics announced the sixth annual Blue & Gray Cleanup Day on April 22, 2026. Approximately 100 student-athletes, coaches, and athletic department staff will volunteer alongside TDOT and Keep Tennessee Beautiful to clean streets around the University of Memphis campus and surrounding neighborhoods.

March 2026 CA BVNPT Vocational Nursing and Psychiatric Technician Disciplinary Actions Index

The California Board of Vocational Nursing and Psychiatric Technicians published its March 2026 disciplinary actions index, documenting 15 accusations filed against vocational nurses and psychiatric technicians from March 9 through March 30, 2026, and 25 citations issued during the same period covering early March through late March 2026. The index also records 14 final decisions and orders filed from March 4 through March 30, 2026, with license numbers spanning both VN and PT credential types.

Reynolds Defends HHS Director After Senate Confirmation Rejection

Iowa Governor Kim Reynolds issued a statement defending HHS Director Larry Johnson after Iowa Senate Democrats voted against his confirmation. The Governor criticized the vote as politically motivated and outlined Johnson's accomplishments, including securing a $209 million federal Rural Health Transformation grant and implementing Iowa's Healthy Hometowns plan.

Coroners and Medical Examiners Disposition of Decedents' Personal Property Provisions Modifications

Minnesota Senate File 4661 proposes modifications to provisions governing coroners and medical examiners regarding disposition of decedents' personal property. The bill passed the State and Local Government Committee on March 23, 2026, and received a committee report to pass before being re-referred to the Judiciary and Public Safety Committee on April 7, 2026. The legislation is sponsored by Sen. Ann Johnson Stewart (D) in the 94th Legislature (2025-2026).

SF4889 Noncommercial Radio Station Grants Eligibility Modifications

Minnesota Senate Bill SF4889 passed committee referral, modifying eligibility requirements for noncommercial radio station grants and establishing an appropriation. The bill was introduced by Sen. Heather Gustafson (D) and referred to the Finance Committee after passing the State and Local Government Committee.

Minnesota SF4687 Removes Consumer Protection Restitution Account Deposit Limit

Minnesota Senate Bill SF4687 passed its chamber, removing the deposit limit on the state's consumer protection restitution account while establishing new distribution limits. The bill was sponsored by Sen. Ann Rest and referred to the Finance Committee after passing Commerce and Consumer Protection. The 94th Legislature session runs through 2026.

SF4776 DHS Child Services Forecast Modifications Passed

The Minnesota Senate passed SF4776 on March 25, 2026, implementing forecast adjustments for the Department of Human Services and the Department of Children, Youth, and Families. The bill was introduced by Sen. Melissa Wiklund (D) and referred through the Health and Human Services Committee before advancing to the Finance Committee for passage. As a technical state budget and forecasting modification, this bill affects administrative processes within Minnesota's child welfare and social services departments.

SF4531 Mental Health Grants Appropriation Passes Minnesota Senate

Minnesota Senate passed SF4531, a mental health grants appropriation bill, on March 17, 2026 during the 94th Legislature (2025-2026). The bill was sponsored by Sen. Melissa Wiklund (D). The legislation was referred to the Finance committee after advancing through Health and Human Services and Judiciary and Public Safety committees, with a committee report to pass issued on April 7, 2026.

Omnibus Cannabis Bill SF4401 Passes Minnesota Senate

Minnesota Senate Bill SF4401, an omnibus cannabis bill, passed the full Senate on March 12, 2026, advancing to the next stage of the legislative process. The bill was introduced on March 11, 2026, by sponsors David Dibble and Lindsey Port, and was referred to the Commerce and Consumer Protection Committee before being re-referred to the Finance Committee on April 7, 2026, with a 'do pass as amended' recommendation. The bill awaits further legislative action before becoming law.

Electronic Monitoring in Employment Settings Bill Passes Minnesota Senate

The Minnesota Senate passed SF4686 on March 23, 2026, a bill regulating the use of electronic monitoring tools in employment settings. The bill was sponsored by Senators Erin Maye Quade and Jen McEwen, advanced from the Labor Committee, and was referred to the State and Local Government Committee with a recommendation to pass as amended. The legislation now proceeds for House consideration as part of the 94th Legislature (2025-2026) session.

Minnesota SF4749 Creates Task Force on Housing Taxes and Fees

Minnesota SF4749 passed the Senate on March 23, 2026, establishing a Task Force on Housing Taxes and Fees. The bill was introduced March 20, 2026, advanced through committee referrals in Housing and Homelessness Prevention, State and Local Government, and Taxes, and was amended before passage. The task force's mandate, membership, and timeline for reporting recommendations will be determined through the bill's further legislative progress.

SF4419 Prescription Drug Transaction, Coverage, and Data Provisions

Minnesota Senate File SF4419, sponsored by Sen. Melissa Wiklund (D), has passed the Senate as of March 12, 2026. The bill addresses prescription drug transaction, coverage, and data provisions. The bill was introduced March 12, 2026, received committee review in Health and Human Services and Commerce and Consumer Protection, and passed the Senate chamber before being re-referred to the Health and Human Services Committee on April 7, 2026.

Massachusetts Bill S1073 Relative to Capacity Determination by Health Care Provider

Massachusetts Senate Bill S1073, concerning capacity determination by healthcare providers, passed the Senate Ways and Means Committee on April 2, 2026, advancing from its referral to the committee following a favorable report. The bill, sponsored by Senator William Driscoll, was introduced on February 27, 2025, and referred to the Joint Committee on the Judiciary before being redirected to the Joint Committee on Health Care Financing and subsequently to Senate Ways and Means. The legislation now awaits further action in the Senate chamber.

S149 Enhances Autism and Developmental Disability Care Standards

Massachusetts Senate Bill S149 has passed the legislature, sponsored by Senator Jason Lewis. The bill aims to increase medical providers' knowledge about autism and intellectual and developmental disabilities to improve treatment. It was referred to the Joint Committee on Children, Families and Persons with Disabilities on February 27, 2025, and reported favorably by the Joint Committee on Health Care Financing before being recommended ought to pass by the Senate Ways and Means Committee on April 2, 2026.

Allianz Risk Transfer AG Portfolio Cession to Allianz Global Corporate & Specialty SE

The National Bank of Belgium has published a public notice regarding the portfolio cession from Allianz Risk Transfer AG to Allianz Global Corporate & Specialty SE, published on 17 April 2026. The transfer concerns insurance and reinsurance activities within the supervised financial sector. This notice is available in the Belgian Official Gazette with reference to the public consultation mechanism under Belgian financial supervisory law.

FERC Public Notice Off-the-Record Communications, RM98-1

FERC issued a formal public notice on April 21, 2026, addressing records governing off-the-record communications under Rulemaking docket RM98-1-000. The notice was filed and issued on the same date and is accessible via the FERC eLibrary system. This appears to be an administrative filing related to FERC's procedures for handling off-the-record communications.

Team ASSURE Wins NUS-SYNAPXE-IMDA AI Innovation Challenge 2026

Team ASSURE from the NUS Master of Science in Business Analytics programme won the $10,000 top prize at the NUS-SYNAPXE-IMDA AI Innovation Challenge 2026 for AssureCare Suite, an AI-enabled home monitoring platform for elderly heart patients. The platform features AssureBot, a voice-enabled AI companion that conducts daily check-ins and captures symptom updates through natural speech, complemented by a Caregiver Portal offering patient status views and escalation alerts. The 12th annual Challenge attracted 880 students from 18 institutes across Singapore, forming 181 teams to develop AI-powered solutions for chronic conditions affecting approximately 1.8 million people in Singapore.

Anti-bot Verification Page Blocks Legal Case Access

BAILII (British and Irish Legal Information Institute) deployed Anubis, a proof-of-work anti-bot system, to protect its Scotland recent decisions feed against AI scraping. The system requires JavaScript execution and may conflict with privacy extensions like JShelter. The technical measure is described as a placeholder while more sophisticated browser fingerprinting is developed.

Access Blocked by Bot Verification Challenge

BAILII Scotland deployed Anubis, a proof-of-work bot verification challenge, across its decision feeds to prevent AI companies from mass-scraping its content. The system presents a JavaScript-based challenge page before serving actual case content. The underlying court decision is not accessible via automated access at this time.

FMA Joins Global Initiative Against Unlawful Finfluencers

The Financial Markets Authority (FMA) joined 17 regulatory authorities across the globe in a coordinated Global Week of Action Against Unlawful Finfluencers from 20 April 2026, focusing on enforcement actions, regulatory measures, and consumer awareness campaigns targeting unlawful financial promotions on social media. The FMA contacted 14 finfluencers active across a range of social media platforms to outline relevant legal obligations, resulting in the removal of misleading or harmful content and some finfluencers reducing their services or ceasing to offer services to New Zealanders. The FMA also released updated guidance for both consumers and finfluencers on online money advice, along with a podcast exploring the growth of finfluencers and associated risks.

CBSA Initiates Expiry Review of Anti-Dumping Finding on Rebar from Oman and Russia

The Canadian International Trade Tribunal (CITT) initiated an expiry review on April 20, 2026, of its anti-dumping finding made July 2, 2021 (Inquiry NQ-2020-005) concerning hot-rolled deformed steel concrete reinforcing bar (rebar) from Oman and the Russian Federation. The CBSA has simultaneously launched its own expiry review investigation to determine whether the expiry of the finding is likely to result in continuation or resumption of dumping. Canadian producers, importers, and exporters of subject goods must submit questionnaire responses by May 28, 2026. The CBSA will issue its determination no later than September 17, 2026, with a Statement of Reasons by October 2, 2026.

Canada Initiates Expiry Review of Anti-Dumping Finding on Concrete Reinforcing Bar

On April 20, 2026, the Canadian International Trade Tribunal (CITT) initiated an expiry review of its June 4, 2021 finding concerning the dumping of certain concrete reinforcing bar from Algeria, Egypt, Indonesia, Italy, Malaysia, Singapore, and Vietnam, pursuant to subsection 76.03(1) of the Special Import Measures Act (SIMA). The Canada Border Services Agency (CBSA) has now initiated a parallel expiry review investigation to determine whether the expiry of the finding is likely to result in continuation or resumption of dumping of the subject goods. Canadian producers, importers, and exporters of the subject goods must respond to CBSA questionnaires by May 28, 2026, filed through the ACE e-filing application. CBSA will issue its determination no later than September 17, 2026 and a Statement of Reasons by October 2, 2026. Any party who has not received a questionnaire letter should contact the CBSA SIMA Registry and Disclosure Unit.

VA Cooperative Studies Program Controlled Substances Import Application

The DEA published a notice that VA Cooperative Studies Program, located in Albuquerque, New Mexico, applied on April 9, 2026, to be registered as an importer of Schedule I controlled substances Marihuana Extract (drug code 7350) and Tetrahydrocannabinols (drug code 7370). The company plans to import finished dosage unit products solely for research and clinical trial studies; no commercial sale of FDA-approved or non-approved finished dosage forms is authorized under this registration. Registered bulk manufacturers and applicants may submit comments or objections to the issuance of the proposed registration on or before May 21, 2026.

Quagen Pharmaceuticals LLC Importer Application for Diphenoxylate

The DEA published a notice that Quagen Pharmaceuticals LLC applied on March 4, 2026 to be registered as an importer of Diphenoxylate (Schedule II controlled substance, Drug Code 9170). Comments and objections may be submitted through May 18, 2026. The company plans to import the controlled substance for distribution to its customers.

Royal Emerald Pharma DEA Controlled Substances Application

The Drug Enforcement Administration published notice that Royal Emerald Pharmaceuticals, 14011 Palm Drive, Building B, Desert Hot Springs, California 92240-6845, applied on March 3, 2026 to be registered as an importer of three Schedule I controlled substance basic classes: Marihuana Extract (7350), Marihuana (7360), and Tetrahydrocannabinols (7370). The company plans to import immature plants for continued cultivation under its Bulk Manufacturing registration. Registered bulk manufacturers and applicants may submit electronic comments or written hearing requests on or before May 18, 2026.

Usona Institute Seeks DEA Bulk Controlled Substance Manufacturer Registration

Usona Institute Seeks DEA Bulk Controlled Substance Manufacturer Registration

AJNA Biosciences applies for DEA bulk manufacturer registration

AJNA Biosciences applies for DEA bulk manufacturer registration

Auto Financing Proposed Rule Supporting Material

The FTC has published supporting material for a proposed rule on auto financing. The document is available as a downloadable PDF on regulations.gov under docket FTC-2026-0397. No substantive provisions, obligations, or deadlines are visible in the source index.

Andrew Gonzalez Indirect Auto Lending Disclosure Petition

The FTC received a petition for rulemaking from Andrew Gonzalez requesting to mandate disclosures regarding indirect auto lending. The Commission has opened a public comment period, with comments due by May 21, 2026. After the comment period closes, the FTC may grant or deny the petition in whole or in part, or determine the petition is insufficient to warrant commencement of a rulemaking proceeding.

FTC Rulemaking Petition by Andrew Gonzalez

An individual identified as Andrew Gonzalez has filed a petition with the Federal Trade Commission requesting rulemaking action. The petition was submitted through the official regulations.gov portal under docket FTC-2026-0397. The submission page indicates a character limit of 5000 for public comments. The petition content itself is not displayed in the source document, only the comment submission form interface.

Bureau of Prisons Medication Records Collection

NARA published a Federal Register notice on Regulations.gov seeking public comments on a Bureau of Prisons information collection request concerning medication records. The notice opens a 30-day comment period for stakeholders to provide feedback on the proposed collection. Comments are due by June 5, 2025.

NARA Records Disposition Authority Request, Comments Due Jun 5

NARA is seeking public comments on a proposed records disposition authority request. The document, identified as NARA-26-0199-0006, invites feedback from the public on federal records management matters. Comments are due June 5, though the year is not specified in the source document.